Conclusion CA19-9 self is not an absolute tumor marker.
结论CA19 - 9本身并不完全是肿瘤标志物。
Objective To study the expressions of the tumor associated antigen, CA19-9 in gastric cancer.
目的研究肿瘤相关抗原CA19—9在胃癌组织中的表达情况。
Objective To appraise the clinical significance of serum CA19-9 changes in choledocholithiasis patients.
目的探讨胆总管结石患者血清CA19 9变化的临床意义。
Objective:To explore the value of combining CA19-9 and CA125 in diagnosis and prognosis of ovarian cancer.
前言： 目的：探讨CA12 5、CA19 9联合检测在卵巢上皮癌诊断及疗效观察中的意义。
Methods Serum CEA and CA19-9 of 240 patients admitted to internal digestive wards were examined with RIA method.
方法以放射免疫法测定240例本院消化内科病房患者的CEA和CA19 - 9血浓度。
The plasma levels of CEA and CA19-9 were determined by microparticle enzyme-linked immunoassay (MEIA) before operation.
微粒子酶联免疫荧光法（MEIA）检测大肠癌患者术前血浆CEA、CA19-9水平。
The levels of expression of CA242 and CA19-9 in carcinoma of colon and rectal carcinoma were with significant differences.
CA19蛳9分别在结肠癌和直肠癌中的表达水平不同，其差异具有显著性意义。
Objective To set up a liquid chip system for the detection of the tumor markers AFP, CEA, CA19-9 and CA125 in clinical practice.
目的：建立液相蛋白芯片测定afp、CEA、CA19 - 9、CA125等肿瘤标志物的方法，讨论其应用于临床检验的可行性。
Conclusion Both imaging modalities and CA19-9 have their advantages and disadvantages in diagnosing malignant obstructive jaundice.
结论影像学检查和血清CA19 9检测诊断恶性梗阻性黄疸各有优势与不足。
Results Malignant cells were found in bile from 26 of 39 malignant obstruction (66.7%), and serum CA19-9 was positive in 28 (71.8%).
结果39例胆道恶性狭窄病例中胆汁细胞学检查阳性26例，敏感性66.7%，血清CA19-9检测阳性28例，敏感性71.8%；
Serum CA19-9 could be used as an aid in detecting digestive system neoplastic disease; it is a reliable marker for pancreatic neoplasm.
这说明血清CA19- 9是一项协诊消化系统肿瘤，特别是胰腺肿瘤的可靠实验室指标；
Objective:1. Observation the value of serum CA19-9 in diagnosis and differential diagnosis of hepatobiliary and pancreatic diseases; 2.
目的：1。观察血清CA19-9在肝胆胰良恶性疾病中的诊断和鉴别诊断价值；
Conclusion: The value of CA242, CA19-9 and CEA by application of protein chip diagnosis system is reliable, with ideal diagnostic value.
结论蛋白芯片法检测CA242,CA19 - 9和CEA结果可靠，对胰腺癌的诊断有一定的价值。
Objective: To assess the value of levels of CA19-9 and CEA in serum and ascites in the diagnosis of malignant tumor in digestive system.
目的：评价血清和腹水中CA19 - 9、CEA含量变化对消化系统恶性肿瘤的诊断价值。
Objective to investigate the changes of serum high-sensitivity C-reactive protein and CA19-9 in postoperative patients with gastric cancer.
目的探讨胃癌患者手术治疗前后检测血清高敏c反应蛋白及CA19 - 9的临床意义。
Methods Serum CYFRA21-1 and CA19-9 levels in 74 patients with gastrointestinal malignant tumors and 35 healthy controls were measured by IRMA.
方法：采用免疫放射度量分析法(irma)法测定74例胃肠道恶性肿瘤患者和35例健康对照者的血清cyfra21 - 1和CA19 - 9含量。
Objective: To investigate the clinical value of CA242 and CA19-9 (tumor marker) in the diagnosis, treatment and prognosis of colorectal cancer.
目的：评价肿瘤标志物CA242与CA19 - 9在大肠癌诊断、治疗和预后中的临床意义。
Draw ROC curve to determine the best positive CA19-9 reference values to improve its diagnostic value of hepatobiliary and pancreatic diseases.
绘制ROC曲线确定CA19 - 9的最佳阳性参考值以提高其对肝胆胰疾病的诊断价值。
Objective To evaluate the diagnostic value and the clinical significance for measuring the serum levels of CA19-9 and CEA in gastrointestinal cancer.
目的通过对外周血中CA19 - 9、CEA的联合检测，探讨其对消化道恶性肿瘤的诊断价值及临床意义。
Objective To highlight the characteristics of Idiopathic pulmonary fibrosis(IPF) with marked elevated serum carbohydrate antigen sialyl Lewis(a)(CA19-9).
目的提高对CA19 9显著升高的特发性肺纤维化（IPF）的认识，评价CA19 9的升高与IPF进展的相关性。
Methods Preoperative serum CEA, CA19-9, and CA242 were measured in 105 pancreatic cancer, 70 non-pancreatic malignance, and 30 benign pancreatic diseases.
方法回顾性分析了105例胰腺癌患者，70例非胰腺外分泌恶性肿瘤以及30例胰腺良性疾病患者术前血清CEA、CA19-9和CA242水平。
The function of transplanted liver recovered smoothly, and the endocrine and exocrine functions of pancreas were kept well. CA19-9 dropped to the normal levels.
肝移植后患者肝功能恢复顺利，胰腺内、外分泌功能保持良好，CA19-9降至正常。
Conclusions CA125 is a good index for CHF diagnosis and assessment, which is related to the severity of CHF, however, there is no significant relationship between CA19-9 levels and CHF.
结论CA125是诊断和评价慢性心衰的一个良好指标，且与心衰程度相关，而CA19 - 9与心衰无明显关系。
Objective To observe the changes of the levels of serum tumor markers, i. e. CA19-9, CA242 and CEA, and their significance during the interventional chemotherapy for pancreatic carcinoma.
目的观察胰腺肿瘤介入化疗术前后相关血清肿瘤标志物糖链抗原19 9（CA19 9）、糖类抗原2 4 2（CA2 4 2 ）及癌胚抗原（CEA）的水平变化及其意义。
Objective To explore the clinical value of combined detection of alpha fetoprotein(AFP), carcinoembryonic antigen(CEA), CA125 and CA19-9 in the diagnosis of malignant tumors in digestive system.
目的探讨联合检测血清中肿瘤标志物甲胎蛋白（AFP）、癌胚抗原（CEA）、糖类抗原125（CA125）、CA19-9对消化系恶性肿瘤的诊断价值。
Objective To probe the clinical evaluation of tumor specific growth factor(TSGF), carbohydrate 19-9(CA19-9) and carbohydrate 242(CA242) combinedly in detecting malignant tumors in digestive tract.
目的探讨用恶性肿瘤特异性生长因子（TSGF）、糖抗原19 9（CA19 9）与糖抗原2 42 （CA2 42 ）联合检测对消化道恶性肿瘤的临床评价。
A novel immunosensor for the determination of carcinoma antigen-19-9(CA19-9) is made by immobilization of horseradish peroxidase(HRP) labeled CA19-9 antibody on colloidal gold carbon paste electrodes.
通过固定辣根过氧化酶（HRP）标记CA19-9抗体在纳米金修饰的碳糊电极制备了CA19-9安培免疫传感器。
Conclusion CA19 9 is an effective tumor marker in diagnosing, deciding whether the tumor has been radically resected and in monitoring its response to the treatment.
结论CA19 9是诊断胆管癌是否被彻底切除，以及监测该病治疗反应有效的肿瘤标志物。
Objective To investigate the clinical significance of CA19 9 in early diagnosis and postoperative prognosis of patients with pancreatic carcinoma.
目的探讨CA 199的检测对胰腺癌早期诊断及术后预后判断的临床意义。
Objective To investigate the clinical significance of CA19 9 in early diagnosis and postoperative prognosis of patients with pancreatic carcinoma.
目的探讨CA 199的检测对胰腺癌早期诊断及术后预后判断的临床意义。
应用推荐